Anne Chi is the Executive Chair of Asia, leading the Asia regional business. During her 30 years of professional experience, Ms. Chi has advised MNC clients on market entry strategy, competitive strategy, regulatory and government policies analysis, product launch strategy assessments, M&A, and in/out-licensing opportunity analyses. She has also worked as an executive in different multinational companies with extensive experience in business development, cross-cultural management, government relations, key account acquisition, conflict resolution, and crisis management.

Ms. Chi has 30 years of professional consulting and operational experience in the pharmaceutical, medical device, and biotech industries in Asia, with a focus on Greater China.

Between 1990-1994, Ms. Chi was general manager of a Sino-Taiwanese medical devices joint venture responsible for establishing the JV and its operation in China. During these years, she had full P&L responsibility, established the national sales team and distribution network, led the effort of establishing the KOL program in China, and negotiated major contracts with healthcare institutions. Ms. Chi gained live experience running the operations in China from company setup and manufacturing to national distribution and sales, as well as government relations and market access.

Ms. Chi also led an international consulting firm as general manager focusing on the Asia Pacific region, serving top-ranked multinational pharmaceutical companies across a wide range of therapeutic areas including respiratory, CNS, immunology, oncology, diabetes, vaccines, and infectious disease. In devices, Ms. Chi has particular experience in diagnostic devices, consumer devices, cardiac intervention devices, and orthopedic devices.